Muhammad Aqib Faizan: The Role of Novel Anticoagulants Factor XI/XIa Inhibitors in the Atrial Fibrillation Population
Muhammad Aqib Faizan, Clinical Intern at District Headquarter Hospital, MTI, DIKhan, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”New study
I had the privilege of leading this study regarding the role of novel anticoagulants FactorXI/XIa inhibitors in atrial fibrillation population (high-thromboembolic-risk patients (mean CHA2DS2-VASc scores 3.9-5.0).
The findings offer a compelling trade-off.
- Significantly lower risk of bleeding across all doses
- Fourfold rise in ischemic stroke
- No significant difference in cardiovascular death, all-cause mortality, or major adverse events indicates general tolerance and neutrality in survival outcomes.
This profile may offer a lifeline for high-risk patients-those in whom bleeding concerns limit traditional anticoagulation.
But the fourfold increase in ischemic stroke is a critical signal.
Proud of what this team accomplished. Huge thanks to Tooba Rehman, Zeyad Kholeif, Fatima Saeed, Jibran Ikram, Alina Tanvir, Carlos Alberto E., Saad Ahmed Waqas, and our mentor, Luis Cerna, whose insights made this happen.”
Title: Dose-Response Efficacy and Safety of Factor XI/XIa Inhibitors in Atrial Fibrillation; a Systematic Review and Meta-Analysis With Subgroup Exploration and Trial Sequential Validation
Authors: Muhammad Aqib Faizan, Tooba Rehman, Mrunalini Dandamudi, Jaivardhan A. Menon, Victoria Zecchin Ferrara, Zeyad Kholeif, Alina Tanvir, Fatima Saeed, Jibran Ikram, Moiuz Chaudhri, Carlos Espiche, Main Muhammad Salman Aslam, Zainab Humayun, Ahmad Mustafa Khalid, Saad Ahmad Waqas, Raheel Ahmad, Luis Cerna
Read the Full Article on Clinical Cardiology.
Stay updated with Hemostasis Today.
-
Jun 8, 2026, 06:30Caryn Blumenfeld: Team Zakophilia and Ratner’s Runners Even Though It’s A Walk!
-
Jun 8, 2026, 06:25Cécile Jefford: The NEHA Community and the Power of Human Connection
-
Jun 8, 2026, 06:02Manoj K: How Incyte Could Help Transform Care for Patients With von Willebrand Disease
-
Jun 8, 2026, 03:05Shamsunisha Yusuff: Iron Down, Platelets Up in a Young CBC ?
-
Jun 8, 2026, 03:03Samwel Mikaye: D-Dimer – A Marker of Blood Clot Breakdown
-
Jun 8, 2026, 02:59Vinita Madhuri: Our Engagement, A Lifeline for Thalassemia Patients
-
Jun 7, 2026, 22:11Lucia Härtel: Exercise, IL-10 Signaling, and Post-Stroke Brain Plasticity
-
Jun 7, 2026, 19:35Ashish Pemawat: Is the 4.5-Hour Thrombolysis Window Becoming Less Relevant?
-
Jun 7, 2026, 18:25Nita Radhakrishnan: Every Child Cured Is a Reminder of What Can Be Achieved When We Work Together